Assessing the Likely Harms to Kidney Vendors in Regulated Organ Markets

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947041

Assessing the Likely Harms to Kidney Vendors in Regulated Organ Markets
Julian Koplin
The American Journal of Bioethics
Volume 14, Issue 10, 2014 pages 7-18
DOI:10.1080/15265161.2014.947041

Abstract
Advocates of paid living kidney donation frequently argue that kidney sellers would benefit from paid donation under a properly regulated kidney market. The poor outcomes experienced by participants in existing markets are often entirely attributed to harmful black-market practices. This article reviews the medical and anthropological literature on the physical, psychological, social, and financial harms experienced by vendors under Iran's regulated system of donor compensation and black markets throughout the world and argues that this body of research not only documents significant harms to vendors, but also provides reasons to believe that such harms would persist under a regulated system. This does not settle the question of whether or not a regulated market should be introduced, but it does strengthen the case against markets in kidneys while suggesting that those advocating such a system cannot appeal to the purported benefits to vendors to support their case.

[Clark]

Not to mention the harms we're experiencing under our existing system. Get it right, first. Then we can talk about adding sellers into the mix. Not before.

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947787

A Fuller Picture of Organ Markets
DOI:10.1080/15265161.2014.947787
I. Glenn Cohen
pages 19-21

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947802

Avoiding Harms to Kidney Vendors through Legal, Regulated Markets
DOI:10.1080/15265161.2014.947802
James Taylor
pages 21-22

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947048

Organ Markets: Problems Beyond Harms to Vendors
DOI:10.1080/15265161.2014.947048
Alexander M. Caprona*, Gabriel M. Danovitchb & Francis L. Delmonicoc
pages 23-25

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947797

Harms to Vendors: We Should Discourage, Not Prohibit Organ Sales
DOI:10.1080/15265161.2014.947797
Alberto Giubilinia*
pages 25-27

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947799

A Further Lesson From Existing Kidney Markets
DOI:10.1080/15265161.2014.947799
Erik Malmqvista*
pages 27-29

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947798

Are Kidney Markets Morally Permissible If Vendors Do Not Benefit?
DOI:10.1080/15265161.2014.947798
Samuel J. Kersteina*
pages 29-30

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947047

All the More Reason: Why Julian Koplin Should Support a Trial of Incentives for Organ Donation
DOI:10.1080/15265161.2014.947047
Benjamin Hippena*
pages 31-33

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947801

Regulated Organ Market: Reality Versus Rhetoric
DOI:10.1080/15265161.2014.947801
Monir Moniruzzamana*
pages 33-35

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947044

A Closer Look at the Iranian Model of Kidney Transplantation
DOI:10.1080/15265161.2014.947044
Kiarash Aramesha*
pages 35-37

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947042

The Truth About Iran
DOI:10.1080/15265161.2014.947042
Sigrid Fry-Reverea*
pages 37-38

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947043

Playing Into the Hands of the Promarket Campaigners
DOI:10.1080/15265161.2014.947043
Miran Epsteina*
pages 39-40

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947443

Paid Living Kidney Transplantation in Iran: Rethinking the Challenges
DOI:10.1080/15265161.2014.947443
Atieh Pajouhia, Farzaneh Zahedia, Zeinab Pajouhia & Bagher Larijanib*
pages 40-42

[Clark]

http://www.tandfonline.com/doi/full/10.1080/15265161.2014.947046

Mistakes and Kidneys
DOI:10.1080/15265161.2014.947046
Ryan Tonkensa*
pages 42-44